App that anticipates weather and environmental threats
Post-money valuation โ
$95.7M
As of Aug 2024 ยท from ACME Altronomatic Common Stock 2 ยท pre-money + amount raised, not a traded price
Total raised
$10,298,404
Across 3 rounds since 2023
Latest share price
$3.75
ACME Altronomatic Common Stock 2 offering price
Financials
FY2021โFY2025 ยท from SEC filings ยท hover any figure for its source
$8.3M
$356K
2021
$8.2M
$44K
2022
$9.0M
โ$1.5M
2023
$10.3M
โ$5.3M
2024
$11.1M
โ$3.7M
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$8,291,021
$8,195,946
$8,954,131
$10,292,290
$11,092,568
Cost of goods sold
$0
$0
$0
$15,065,988
$14,205,934
Gross margin
100%
100%
100%
-46%
-28%
Net income
$355,570
$44,026
-$1,457,614
-$5,292,058
-$3,654,247
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$755,547
$250,379
$209,370
$271
$24,220
Accounts receivable
$0
$149,806
$1,046,882
$1,789,509
$1,853,793
Total assets
$1,036,360
$438,399
$1,060,580
$1,789,780
$2,046,817
Short-term debt
$0
$507,616
$596,613
$2,369,065
$2,158,390
Long-term debt
$349,742
$355,681
$2,333,978
$256,345
$968,497
Total liabilities
$349,742
$863,297
$1,980,465
$2,625,410
$3,126,887
Other
Headcount
โ
28
34
37
42
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.